Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis

NCT: NCT03812016 · RECRUITING

NCT IDNCT03812016
StatusRECRUITING
Start Date2023-04-01
Completion2028-05-31
SponsorE-DA Hospital (OTHER)
First posted
Last updated

Brief Summary

To develop a feedback-enabled magnetic device for management of blepharoptosis and evaluate its efficacy and safety, including the gain of palpebral fissure height, visual field obstruction, blurred vision, foreign body sensation over the cornea, burning or hot sensation over facial skin, and erythema or pruritus over the eyelid, by performing a human trial on patients with blepharoptosis.

Frequently Asked Questions

What is A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis?

A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis is a clinical trial registered under NCT03812016. Current status: RECRUITING.

What is the status of NCT03812016?

The current status of NCT03812016 (A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis) is: RECRUITING.

When did A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis start?

A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis started on 2023-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.